TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
2023年11月16日 - 9:00PM
TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical
technology company focused on providing innovative soft-tissue
reconstruction solutions that optimize clinical outcomes by
prioritizing the preservation and restoration of the patient's own
anatomy, today announced that the Company will participate in Piper
Sandler’s 35th Annual Healthcare Conference.
TELA’s management is scheduled to present at
Piper Sandler’s 35th Annual Healthcare Conference at 11:00 am ET on
November 30th, 2023. Interested parties can access the live and
archived webcast at ir.telabio.com.
About TELA Bio, Inc.TELA Bio,
Inc. (NASDAQ: TELA) is a commercial-stage medical technology
company focused on providing innovative technologies that optimize
clinical outcomes by prioritizing the preservation and restoration
of the patient's own anatomy. The Company is committed to providing
surgeons with advanced, economically effective soft-tissue
reconstruction solutions that leverage the patient's natural
healing response while minimizing long-term exposure to permanent
synthetic materials. For more information, visit
www.telabio.com.
Investor ContactGreg
Chodaczek347-620-7010ir@telabio.com
TELA Bio (NASDAQ:TELA)
過去 株価チャート
から 4 2024 まで 5 2024
TELA Bio (NASDAQ:TELA)
過去 株価チャート
から 5 2023 まで 5 2024